LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Lactic acid and biosurfactants from food waste for sustainable cleaning products

17/10/2024

CASE STUDY

Submission from  bio.be/essenscia

The innovation.

Lactic acid and biosurfactants are currently produced commercially, primarily via fermentation from first generation sugar. The majority of this sugar is produced from sugar canes in Brazil and then imported into the EU, making the production processes dependent on that supply. Additionally, there is ongoing debate on the ethics of using potential human food as a fermentation feedstock. Therefore, it is key to also investigate potential production of these molecules using other sugar sources.

In the CBE-JU project WASTE2FUNC, the consortium partners enabled the production of biosurfactants and lactic acid from agricultural food waste, the food industry, supermarkets and restaurants. Technology owners AmphiStar (Biosurfactants) and TripleW (Lactic Acid) in close collaboration with Bio Base Europe Pilot Plant as the scale-up facility, optimised and demonstrated the production of these molecules. The lactic acid and biosurfactants were tested in several formulations and were eventually incorporated in the prototypes created by project partner Ecover, as part of the “Too good to waste” campaign. This marked the first demonstration of waste-based lactic acid and biosurfactants in home care products.

The benefits.

The innovations in this project opened the door for both technology owners. AmphiStar secured €6 million private funding to launch eco-friendly and cost-effective biosurfactants derived from waste and is also a key partner in the WASTE2FUNC follow-up CBE-JU project SURFs UP. In this project, AmphiStar will launch its first demonstration plant to take the next steps in bringing their innovation to the market. Meanwhile, TripleW launched several CIRCULAC ™ products and, with Series B funding of $16,5 million in 2023 and the €17 million WASTE2FUNC CBE-JU follow-up project CIRCLE that kicked-off in September 2024, TripleW will build its first of flagship plant in the Netherlands to enable the commercial production of waste-based lactic acid. Both innovations have laid the groundwork for reducing dependence on first-generation sugar in fermentation processes. These technologies and their benefits are also highlighted in the WASTE2FUNC project video.

Lactic acid and biosurfactants from food waste for sustainable cleaning products


Download

Share
Communications Team
Communications Team

Related posts

14/11/2025

Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech


Read more
12/11/2025

EuropaBio response to the EU Biotech Act public consultation


Read more
05/11/2025

EuropaBio recommendations for the Circular Economy Act


Read more

Important links

  • Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech
  • EuropaBio response to the EU Biotech Act public consultation

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.